IG Punjab releases additional Rs2.618m
Punjab Police spokesperson, while sharing details, said that Rs. 1 million in funds were released for the treatment of the brain tumour of the widow of late Constable Khalid Mehmood. Inspector Muhammad Khalid Imran was given Rs. 225,000 for his wife's cancer treatment.
Similarly, Rs. 200,000 each were released for the treatment of Inspector Mehmood Butt, Sub-Inspector Ajmal Khan, and Driver Constable Jafar Ali. Retired ASI Muhammad Safdar, Constables Muhammad Naveed and Ghazanfar Mehmood were each given Rs 100,000 for their treatment. Constable Waqas Liaqat, Intelligence Operator Muhammad Mohsin, and Washerman Asghar Ali were given a total of Rs. 200,000 for medical treatment.
Assistant Tariq Mehmood, Lady Constable Shaheen Afzal, and driver constable Muhammad Asad were issued a total of Rs 293,000 for their treatment.
IG Punjab approved the release of the funds after scrutiny by the Medical Financial Assistance Committee.
Dr. Usman Anwar said that under MoUs with various institutions, the department is also providing employees with the best medical treatment facilities.
Copyright Business Recorder, 2025
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Express Tribune
3 hours ago
- Express Tribune
HPV vaccine to roll out in Sindh, addressing technical but not social gaps
The human papillomavirus (HPV) vaccine to prevent cervical cancer will be rolled out from September 15 in Sindh, with health officials warning that community mistrust, persistent rumours and gaps in vaccinator training could undermine the campaign. Around 50% of the target group is enrolled in schools, with coordination underway [between health officials and the] education department to facilitate in-school vaccinations, said Dr Rehan Baloch, speaking at the Globe HPV Seminar at Aga Khan Univeristy (AKU). 'We have earmarked around Rs 200 million for the HPV vaccine, with additional support from Gavi and other partners for advocacy and outreach,' he said, stressing the need for stronger engagement with parents, teachers and healthcare providers. The campaign will rely on paediatricians, gynaecologists and frontline workers to inform communities about HPV and cervical cancer prevention. Photo Courtesy: AKU Sindh Expanded Programme on Immunisation (EPI) Project Director Dr Raj Kumar described the rollout as a 'historic initiative' and said preparations were focused on operational logistics and microplanning at the union council level, drawing on experience from measles, typhoid and polio campaigns. Officials said 20 million girls aged nine to 14 are registered in schools nationwide, with the remainder out of school. An estimated 70% of vaccinations will take place in schools and the rest are to be administered in community settings through partnerships with public and private sectors. What is HPV? Cervical cancer kills more than 300,000 women worldwide each year, with the heaviest death toll in low- and middle-income countries. In Pakistan, the disease is among the leading cancers in women and is often diagnosed too late, despite being largely preventable through timely vaccination. The human papillomavirus (HPV) — a sexually transmitted infection — is responsible for 91% of cervical cancers globally. According to the World Health Organization (WHO), more than 291 million women are diagnosed annually and about 340,000 die from the disease, most in countries like Pakistan. Recent estimates indicate that every year in Pakistan, 5,008 women are diagnosed with cervical cancer and 3,197 die from the disease, according to the Human Papillomavirus and Related Cancers, Fact Sheet 2023. HPV has over 200 known types, classified into low-risk and high-risk categories. While most low-risk infections are asymptomatic and resolve on their own, high-risk strains HPV 16 and 18 are linked to 70–80% of cervical cancer cases. In Pakistan, nine out of 10 cases are caused by these two strains. The country reports about 5,000 new cases and 3,000 deaths each year, with 73–74 million women at risk. The HPV vaccine is most effective for girls aged nine to 14, but coverage is hindered by data gaps, slow rollout and social barriers. Pakistan's age-standardised incidence rate is 6.1 per 100,000 women — above the WHO's recommended threshold of four or fewer. The WHO's 2020 global strategy calls for vaccinating 90% of girls in this age group by 2030, but global uptake remains below 15% due to delays in national programmes. The Zekolin vaccine being introduced in Pakistan protects against HPV types 16 and 18, which modelling by the International Agency for Research on Cancer (IARC) suggests could prevent up to 83% of cervical cancer cases in the Eastern Mediterranean, Central, Western, and Southern Asia. Newer-generation vaccines covering multiple HPV types could increase protection to 95%. Top down approach vs community-led engagement The HPV campaign's success in Sindh will depend not only on logistics but also on addressing deep-rooted social inequities. A technical, top-down approach risks alienating communities already excluded from decision-making, underscoring the need for participatory strategies that treat local populations as equal partners in health initiatives. Pakistan's entrenched health and education inequalities cannot be resolved by technical fixes alone, warned Dr Kausar S Khan, a public health researcher and human rights activist, calling for participatory action research and community-led engagement as the foundation of social policy. The country's policy and academic elite — researchers, senior bureaucrats and service providers — form a small, privileged minority, while 'the poor, women, minorities, transgender people, and those with different sexual orientations' make up the majority yet remain excluded from decision-making, stressed Dr Khan. 'In Karachi, more than 50% of the population lives in kachhi abadis without water, electricity, or sanitation — and yet we want to take science to them,' she said, warning that a science-heavy, top-down approach ignores participatory ethics and local realities. Drawing from her work in participatory action research, Dr Khan urged a 'power-based, strength-based approach' that begins with 'knowing yourself' and treating communities as equal partners rather than passive recipients of awareness campaigns by focusing on women development department for HPV vaccination initiatives. This, she underscored, is lacking in the campaign. However, the assumption that vaccines and other technical interventions can address deep-rooted social problems is incorrect. 'The successes we see are technical. But the social side is where it was,' she said, stressing that performance indicators and programmatic processes cannot replace genuine community inclusion. Gaps and awareness Awareness of cervical cancer and the human papillomavirus (HPV) in Pakistan remains alarmingly low, with entrenched cultural norms and gender dynamics posing major challenges to HPV vaccine uptake, according to findings from the JPEGOS CAHPS study presented by UNICEF's Social and Behavioral Change (SBC) team. The study found that only 17.2% of respondents were aware of cervical cancer, a mere 4.4% of caregivers had heard of HPV, and only 2.9% knew of the HPV vaccine's existence. UNICEF officials said the fear of cancer could be a motivator, but misconceptions about hygiene, fatalistic beliefs, and women's limited role in healthcare decision-making severely hinder acceptance. Language and framing were found to influence perceptions — 'vaccine' evoked hope and prevention for adolescent girls, while 'injection' triggered a fear of needles and illness. UNICEF's co-creation sessions emphasised portraying girls as aspirational subjects rather than vulnerable objects, and using images that reflect real communities instead of idealised versions. Awareness about the HPV vaccine is particularly low, with 95% of people surveyed having never heard of it. However, trust in official guidance is high — 90% said they would accept the vaccine if recommended by the government, a doctor, or religious leaders. Around 76–81% expressed interest in cervical cancer or HPV screening, and 79–80% said they would vaccinate themselves or their daughters. Barriers include access to vaccines, family objections, minor fears about pain or side effects, cost concerns, and embarrassment due to misconceptions about the vaccine's necessity. Reluctance is notably higher among mothers than daughters. Mothers emerged as the key gatekeepers for consent, due to their close communication with daughters, while fathers — often uninvolved in daily health decisions — hold passive approval that can stall campaigns. 'In fact, mothers who exhibited a greater knowledge of cervical cancer showed a more [bigger] risk of not wanting to vaccinate their daughters compared to those who had never heard of it,' noted Dr Fyezah Jehan, Professor and Chair at AKU. 'It is trust and reassurance, and addressing these concerns, that will allow us to manage it better.' She added that acceptance is highest when mothers understand both the benefits and the safety of the vaccine, without having general concerns about childhood immunisation. Social listening efforts by UNICEF and other partners are underway to identify local concerns and adapt communication strategies to build vaccine confidence and prevent hesitancy. Findings indicate that both parents and health workers require targeted engagement. 'We need to convince our vaccinators, our health workers even more that this vaccine is good, and then they will transmit that confidence…to the communities and the key stakeholders,' said Dr Paul Bloem, WHO HPV Vaccine Senior Technical Officer, stressing the need for continuous training to reinforce trust. Despite strong safety data, rumours persist, particularly claims linking the vaccine to infertility. The global vaccine safety committee has repeatedly reviewed such allegations and found 'no association between HPV vaccination and infertility'. Experts note the vaccine may actually help prevent infections that can reduce fertility. Evidence from other countries, such as Bangladesh, shows that careful preparation and adopting a one-dose strategy can achieve national coverage rates above 90% at launch. Officials warn that without similar groundwork in Pakistan, achieving high coverage from the outset — critical for long-term success — will remain out of reach.
Business Recorder
2 days ago
- Business Recorder
SKMCH: SMS donation amount revised upward
LAHORE: Shaukat Khanum Memorial Cancer Hospital (SKMCH) and Research Centre on Monday announced that, effective August 12, 2025, donations made via SMS to 7770 will increase to Rs 100 (plus applicable taxes), from the previous amount of Rs 20 (plus taxes). This increase will enhance your contribution to provide world-class cancer treatment to thousands of underprivileged patients across Pakistan. For nearly three decades, the unwavering generosity of donors has enabled the expansion of Shaukat Khanum's services, including its facility in Peshawar and the near completion of its third hospital in Karachi. Every contribution counts, and an SMS donation of Rs 100 to 7770 can provide hope and life-saving care for cancer patients in need. Dr Faisal Sultan, CEO of Shaukat Khanum Hospitals said, 'We hope that the public will continue their support through this Sadaqah-e-Jariya and give hope to the needy cancer patients.' Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
MDCAT on Oct 5 with Rs9,000 fee: PMDC
ISLAMABAD: The Pakistan Medical and Dental Council (PMDC), Saturday, refuting rumors regarding an 80 percent increase in Medical and Dental Colleges Admission Test (MDCAT) has announced that the MDCAT will be held on Sunday, 5 October 2025, with Rs9,000 admission fee against Rs8,000 last year reflecting an increase of 12.5 percent. While issuing the schedule for the MDCAT exams here, the PMDC said it has come to the notice of that there has been a misunderstanding regarding the MDCAT examination fee, which claims that it has increased by 80 per cent. PMDC clarified that the fee for the MDCAT has increased modestly and gradually over the past years, in 2024, it was Rs.8,000, and for 2025, it has been set at Rs. 9,000. This year, only Rs1,000 have been added to the previous year's fee, which is an increment of 12.5 per cent, not 80 per cent as circulated in the social media. The MDCAT exam is going to be conducted by universities nominated by the federal and provincial authorities, not by PMDC. However, PMDC as a regulator has developed a uniform syllabus for the MDCAT in consultation with all the stakeholders, including federal and provincial authorities. The PMDC has also invested heavily in developing a question bank based on a common syllabus agreed upon by the provinces. The Council decided to revise the fee on request of the examination-conducting universities due to the rising costs of paper printing, enhanced security protocols and logistical arrangements, payments for examiners, invigilators, and administrative staff and ensuring adequate seating and facilities for candidates nationwide and international venues. Despite significant inflation and increasing operational costs, PMDC remains steadfast to affordability and fairness. The Council has taken a balanced approach to ensure that the exam remains accessible to all candidates while maintaining quality and integrity in the testing process. PMDC reaffirms transparent, responsible, and merit-based admissions, ensuring equal opportunities for all aspiring medical and dental students. The MDCAT will be conducted through the following admitting/test conducting universities, ie, University of Health Sciences, Lahore (for Punjab Province), Sukkur IBA University, Sukkur (for Sindh Province), Khyber Medical University, Peshawar (for Khyber Pakhtunkhwa Province), Bolan University of Medical and Health Sciences Quetta (for Balochistan Province), Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad (for Islamabad Capital Territory, Azad Jammu and Kashmir, Gilgit-Baltistan and for international Riyadh, Saudi Arabia). The schedule for MDCAT-2025 online registration for both local and international candidates began on 8th August 2025 and will close on 25th August 2025. After this date, registration will only be accepted with a late fee, which will remain open until 1st September 2025. The candidates must carefully select one city/centre for the MDCAT and fill out the application with all necessary requirements otherwise, the online system will reject the application. The test will be a paper-based, multiple-choice exam conducted in English, comprising 180 MCQs with no negative marking, distributed as follows: Biology (81), Chemistry (45), Physics (36), English (9), and Logical Reasoning (9). The curriculum/syllabus is available at and candidates must complete their registration through Incomplete applications will not be accepted. Copyright Business Recorder, 2025
